Skip to main content
HR 9682 119th Congress House Health

Cure Hepatitis C Act of 2026

Introduced: July 14, 2026 Introduced by: Miller-Meeks, Mariannette Republican · Iowa See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 2026
Introduced in House
Jul 14, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cure Hepatitis C Act of 2026

This bill establishes programs and requirements to provide free medications to treat hepatitis C in certain high-risk or vulnerable populations. It also establishes grants and other resources to support testing and treatment for hepatitis C. The bill provides funding for FY2027 to implement these provisions.

The Department of Health and Human Services (HHS) must enter into a five-year purchasing contract with manufacturers of drugs that treat hepatitis C so that eligible individuals may receive the drugs without cost-sharing. Eligible individuals are those diagnosed with hepatitis C who are (1) enrolled in Medicaid or the Children’s Health Insurance Program (CHIP), (2) confined to federal, state, or local correctional facilities (or were released and began treatment there), (3) uninsured, or (4) receiving health care through the Indian Health Service.

State Medicaid and CHIP programs and state and local correctional facilities may opt into the program; participation is mandatory for federal correctional facilities and the Indian Health Service. 

HHS must award grants to certain entities, including states, public health organizations, and correctional facilities, to support the coordination and provision of screening, treatment, and supportive services for the affected populations. 

The bill also allows Medicare beneficiaries to receive hepatitis C drugs without cost-sharing from 2028-2032.

What's happening now July 14, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 9682: Cure Hepatitis C Act of 2026. 119th Congress. Open America. https://openamerica.io/bill/119-HR-9682/
MLA
"H.R. 9682: Cure Hepatitis C Act of 2026." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-9682/.
Bluebook (legal)
H.R. 9682, 119th Cong. (2026), https://openamerica.io/bill/119-HR-9682/.
Markdown link
[H.R. 9682: Cure Hepatitis C Act of 2026](https://openamerica.io/bill/119-HR-9682/)
Report a problem